CRR

mUC - L1 - all population metastatic/advanced UC (mUC) - 1st Line (L1) mUC - L1 - all population

versus placebo plus SoC
atezolizumab plus SoC vs. placebo plus SoC 1 certainty unassessable+96%

mUC - L1 - PDL1 positive metastatic/advanced UC (mUC) - 1st Line (L1) mUC - L1 - PDL1 positive